Melanotan 2: A Lyophilised Melanocortin Peptide Requiring Precise Reconstitution and Cold-Chain Handling
Melanotan 2 is a seven-amino-acid cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH), supplied by Knoll Pharmaceuticals as a lyophilised powder in a 10 mg single-dose vial that must be reconstituted with bacteriostatic water before subcutaneous administration. Unlike pre-mixed liquid peptide solutions, the freeze-dried format preserves molecular integrity for months when kept refrigerated, making proper cold-chain management a critical part of effective use. Knoll Pharmaceuticals certifies each batch through HPLC analysis, confirming that the active peptide content matches label claim before the vial reaches the end user.
Reconstitution: Step-by-Step for Accurate Dosing
Bacteriostatic water is the standard solvent for reconstituting Melanotan 2 because its 0.9 % benzyl alcohol content inhibits microbial growth across multiple draw sessions — plain sterile water lacks this protection and should only be used when the entire vial will be consumed in a single sitting. A common reconstitution ratio is 2 mL of bacteriostatic water per 10 mg vial, yielding a concentration of 5 mg/mL (5,000 mcg/mL); a 0.1 mL draw with a 100-unit insulin syringe therefore delivers 500 mcg per injection. Compared to pre-dissolved peptide vials, which begin degrading immediately upon manufacture, lyophilised Melanotan 2 reconstituted under aseptic conditions retains ≥ 95 % potency for up to 30 days refrigerated, according to standard peptide stability data referenced in pharmaceutical reconstitution guidelines.
Storage, Cold-Chain and Injection Technique
Knoll Pharmaceuticals' lyophilised Melanotan 2 vials should be stored at 2–8 °C (standard refrigerator temperature) prior to reconstitution; the powder must never be frozen once the vial has been punctured. Subcutaneous injection into the pinched skin of the abdomen or thigh is the preferred delivery route: the insulin syringe penetrates at a 45-degree angle, the plunger is drawn back briefly to confirm no blood return, and the dose is deposited slowly into the subcutaneous fat layer. Rotating injection sites session-to-session reduces localised tissue irritation — a practical advantage documented by subcutaneous peptide administration protocols used in clinical peptide research settings.
Key Analytical Assurances
HPLC purity screening confirms Melanotan 2 sequence fidelity at the bulk API stage, while LAL (Limulus Amebocyte Lysate) endotoxin testing verifies sterility of the finished vial. These two checkpoints address entirely separate quality risks: sequence impurity versus pyrogen contamination. Together they form the HPLC-Verified release standard that underpins every Knoll Pharmaceuticals peptide vial.